CSMAX
Price
$14.65
Change
-$0.13 (-0.88%)
Updated
Jul 11 closing price
Net Assets
21.83M
SFCWX
Price
$74.31
Change
-$0.06 (-0.08%)
Updated
Jul 14 closing price
Net Assets
78.5B
Interact to see
Advertisement

CSMAX vs SFCWX

Header iconCSMAX vs SFCWX Comparison
Open Charts CSMAX vs SFCWXBanner chart's image
Calvert Global Small-Cap Equity A
Price$14.65
Change-$0.13 (-0.88%)
VolumeN/A
Net Assets21.83M
American Funds SMALLCAP World F3
Price$74.31
Change-$0.06 (-0.08%)
VolumeN/A
Net Assets78.5B
CSMAX vs SFCWX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSMAX vs. SFCWX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSMAX is a Hold and SFCWX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SFCWX has more cash in the bank: 78.5B vs. CSMAX (21.8M). CSMAX (0.96) and SFCWX (0.94) have matching dividends . CSMAX was incepted earlier than SFCWX: CSMAX (23 years) vs SFCWX (8 years). CSMAX (2.07) is less costly to investors than SFCWX (0.65). CSMAX is a more actively managed with annual turnover of: 46.00 vs. SFCWX (32.00). CSMAX has a lower initial minimum investment than SFCWX: CSMAX (1000) vs SFCWX (1000000). SFCWX annual gain was more profitable for investors over the last year : 6.28 vs. CSMAX (2.61). SFCWX return over 5 years is better than : 20.03 vs. CSMAX (13.96).
CSMAXSFCWXCSMAX / SFCWX
Total Expense Ratio1.310.65202%
Annual Report Gross Expense Ratio2.070.65318%
Fund Existence23 years8 years-
Gain YTD4.5687.93358%
Front Load5%N/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.8M78.5B0%
Annual Yield % from dividends0.960.94102%
Returns for 1 year2.616.2842%
Returns for 3 years20.4935.2858%
Returns for 5 years13.9620.0370%
Returns for 10 years-14.26N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNLI14.690.17
+1.17%
Denali Therapeutics
SGA13.530.11
+0.82%
Saga Communications
FFIV294.152.26
+0.77%
F5, Inc.
PLSE16.070.04
+0.25%
Pulse Biosciences
SXTP2.16-0.35
-14.09%
60 Degrees Pharmaceuticals Inc.